Published in Lancet Infect Dis on December 01, 2003
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol (2009) 3.94
Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis (2008) 3.07
Leptospirosis in the Asia Pacific region. BMC Infect Dis (2009) 2.80
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl Trop Dis (2007) 2.65
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Unifying vertical and nonvertical evolution: a stochastic ARG-based framework. Syst Biol (2009) 2.40
Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun (2007) 2.12
The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog (2007) 1.93
Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis (2015) 1.93
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats. PLoS Negl Trop Dis (2015) 1.92
Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol (2010) 1.89
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res (2004) 1.77
Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PLoS One (2007) 1.74
Leptospirosis after recreational exposure to water in the Yaeyama islands, Japan. Am J Trop Med Hyg (2005) 1.73
Diagnostic accuracy of real-time PCR assays targeting 16S rRNA and lipL32 genes for human leptospirosis in Thailand: a case-control study. PLoS One (2011) 1.70
Leptospirosis in Germany, 1962-2003. Emerg Infect Dis (2005) 1.67
Carriage of Leptospira interrogans among domestic rats from an urban setting highly endemic for leptospirosis in Brazil. Acta Trop (2008) 1.66
Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg (2008) 1.62
LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun (2006) 1.61
Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host. PLoS Pathog (2008) 1.59
Epidemiology of Leptospirosis in Africa: A Systematic Review of a Neglected Zoonosis and a Paradigm for 'One Health' in Africa. PLoS Negl Trop Dis (2015) 1.57
Leptospirosis in humans. Curr Top Microbiol Immunol (2015) 1.56
Osmolarity, a key environmental signal controlling expression of leptospiral proteins LigA and LigB and the extracellular release of LigA. Infect Immun (2005) 1.52
Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun (2006) 1.51
Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect Immun (2006) 1.49
Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis (2012) 1.49
The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine (2007) 1.49
Leptospirosis among hospitalized febrile patients in northern Tanzania. Am J Trop Med Hyg (2011) 1.49
Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis. Infect Immun (2008) 1.46
Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis (2010) 1.46
Case report: severe, symptomatic hypomagnesemia in acute leptospirosis. Am J Trop Med Hyg (2008) 1.45
Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis. J Clin Microbiol (2007) 1.44
Leptospirosis in American Samoa 2010: epidemiology, environmental drivers, and the management of emergence. Am J Trop Med Hyg (2012) 1.42
Response of Leptospira interrogans to physiologic osmolarity: relevance in signaling the environment-to-host transition. Infect Immun (2007) 1.42
Nephropathia epidemica and leptospirosis in Champagne-Ardenne, France: comparison of clinical, biological and epidemiological profiles. Eur J Clin Microbiol Infect Dis (2009) 1.39
Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis. BMC Infect Dis (2011) 1.39
Severe leptospirosis in hospitalized patients, Guadeloupe. Emerg Infect Dis (2010) 1.38
Changes in lipopolysaccharide O antigen distinguish acute versus chronic Leptospira interrogans infections. Infect Immun (2005) 1.36
Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog (2008) 1.34
Underrecognition of leptospirosis during a dengue fever outbreak in Hawaii, 2001-2002. Vector Borne Zoonotic Dis (2008) 1.33
Diversity of bat-associated Leptospira in the Peruvian Amazon inferred by bayesian phylogenetic analysis of 16S ribosomal DNA sequences. Am J Trop Med Hyg (2005) 1.33
Serologic and molecular studies of Leptospira and leptospirosis among rats in the Philippines. Am J Trop Med Hyg (2010) 1.33
Characterization of virulence of Leptospira isolates in a hamster model. Vaccine (2008) 1.32
In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun (2008) 1.31
Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect Immun (2005) 1.31
Development of a Multiple-Locus Variable Number of Tandem Repeat Analysis (MLVA) for Leptospira interrogans and its application to Leptospira interrogans serovar Australis isolates from Far North Queensland, Australia. Ann Clin Microbiol Antimicrob (2005) 1.27
Lsa21, a novel leptospiral protein binding adhesive matrix molecules and present during human infection. BMC Microbiol (2008) 1.26
Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar. Antimicrob Agents Chemother (2012) 1.26
First isolation and direct evidence for the existence of large small-mammal reservoirs of Leptospira sp. in Madagascar. PLoS One (2010) 1.25
Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun (2006) 1.24
Leptospirosis in American Samoa--estimating and mapping risk using environmental data. PLoS Negl Trop Dis (2012) 1.23
A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One (2009) 1.22
Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol (2008) 1.21
Leptospiral pathogenomics. Pathogens (2014) 1.20
Leptospirosis in urban wild boars, Berlin, Germany. Emerg Infect Dis (2007) 1.19
Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis (2013) 1.19
Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete. J Bacteriol (2009) 1.18
Serovar diversity of pathogenic Leptospira circulating in the French West Indies. PLoS Negl Trop Dis (2013) 1.18
A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl Trop Dis (2013) 1.17
Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect Immun (2010) 1.16
Transcriptional responses of Leptospira interrogans to host innate immunity: significant changes in metabolism, oxygen tolerance, and outer membrane. PLoS Negl Trop Dis (2010) 1.16
Comparative and functional genomic analyses of iron transport and regulation in Leptospira spp. J Bacteriol (2006) 1.16
Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis. Clin Vaccine Immunol (2007) 1.16
Clinical and imaging manifestations of hemorrhagic pulmonary leptospirosis: a state-of-the-art review. Lung (2010) 1.15
Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun (2008) 1.15
Leptospira contamination in household and environmental water in rural communities in southern Chile. Int J Environ Res Public Health (2014) 1.14
Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. PLoS Negl Trop Dis (2015) 1.13
Distribution of the leptospiral immunoglobulin-like (lig) genes in pathogenic Leptospira species and application of ligB to typing leptospiral isolates. J Med Microbiol (2009) 1.11
Leptospirosis vaccines. Microb Cell Fact (2007) 1.11
A global research agenda for leptospirosis. J Postgrad Med (2005) 1.11
Genetic affinities within a large global collection of pathogenic Leptospira: implications for strain identification and molecular epidemiology. PLoS One (2010) 1.10
Using death certificate reports to find severe leptospirosis cases, Brazil. Emerg Infect Dis (2007) 1.09
The Jarisch-Herxheimer reaction in leptospirosis: a systematic review. PLoS One (2013) 1.09
Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-κB signaling pathways. PLoS One (2012) 1.09
Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol (2010) 1.08
Comparative transcriptional and translational analysis of leptospiral outer membrane protein expression in response to temperature. PLoS Negl Trop Dis (2009) 1.08
Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun (2010) 1.08
Application and validation of PFGE for serovar identification of Leptospira clinical isolates. PLoS Negl Trop Dis (2010) 1.08
Inactivation of the fliY gene encoding a flagellar motor switch protein attenuates mobility and virulence of Leptospira interrogans strain Lai. BMC Microbiol (2009) 1.07
Comparative proteogenomic analysis of the Leptospira interrogans virulence-attenuated strain IPAV against the pathogenic strain 56601. Cell Res (2011) 1.07
Pancreatitis and myocarditis followed by pulmonary hemorrhage, a rare presentation of leptospirosis- a case report and literature survey. BMC Infect Dis (2013) 1.07
Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods. Am J Trop Med Hyg (2010) 1.07
Global proteome analysis of Leptospira interrogans. J Proteome Res (2009) 1.06
Epidemiology of leptospira transmitted by rodents in southeast Asia. PLoS Negl Trop Dis (2014) 1.06
Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin Vaccine Immunol (2008) 1.06
Transcriptional response of Leptospira interrogans to iron limitation and characterization of a PerR homolog. Infect Immun (2010) 1.05
Leptospira and rodents in Cambodia: environmental determinants of infection. Am J Trop Med Hyg (2012) 1.04
Expression and characterization of an iron-regulated hemin-binding protein, HbpA, from Leptospira interrogans serovar Lai. Infect Immun (2007) 1.04
Impact of proficiency testing on results of the microscopic agglutination test for diagnosis of leptospirosis. J Clin Microbiol (2004) 1.04
A model system for studying the transcriptomic and physiological changes associated with mammalian host-adaptation by Leptospira interrogans serovar Copenhageni. PLoS Pathog (2014) 1.03
Sporadic urban leptospirosis. J Community Hosp Intern Med Perspect (2011) 1.03
The epidemiology of leptospirosis and the emergence of Leptospira borgpetersenii serovar Arborea in Queensland, Australia, 1998-2004. Epidemiol Infect (2006) 1.03
Whole genome analysis of Leptospira licerasiae provides insight into leptospiral evolution and pathogenicity. PLoS Negl Trop Dis (2012) 1.02
Outbreak of leptospirosis among triathlon participants in Germany, 2006. BMC Infect Dis (2010) 1.02
Globalization of leptospirosis through travel and migration. Global Health (2014) 1.02
Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun (2009) 1.01
Identification of seroreactive proteins of Leptospira interrogans serovar copenhageni using a high-density protein microarray approach. PLoS Negl Trop Dis (2013) 1.01
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med (2014) 4.95
Human brucellosis. Lancet Infect Dis (2007) 4.92
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr (2007) 4.67
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol (2007) 3.22
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol (2003) 3.01
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69
Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2003) 2.43
Species identification after treatment for human taeniasis. Lancet (2004) 2.43
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
Does species diversity limit productivity in natural grassland communities? Ecol Lett (2007) 2.30
The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28
Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis (2012) 2.23
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr (2009) 2.15
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg (2008) 2.09
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05
Leptospirosis during dengue outbreak, Bangladesh. Emerg Infect Dis (2005) 2.02
Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother (2002) 2.00
Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol (2004) 1.97
Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis (2013) 1.96
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Cutaneous tuberculosis. Clin Dermatol (2007) 1.92
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90
Human infection with a triple-reassortant swine influenza A(H1N1) virus containing the hemagglutinin and neuraminidase genes of seasonal influenza virus. J Infect Dis (2010) 1.87
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection. J Acquir Immune Defic Syndr (2009) 1.83
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother (2007) 1.81
Similarity of mammalian body size across the taxonomic hierarchy and across space and time. Am Nat (2004) 1.80
Species-specific identification of Leptospiraceae by 16S rRNA gene sequencing. J Clin Microbiol (2006) 1.80
Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop (2011) 1.78
Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci U S A (2010) 1.74
Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics (2006) 1.74
Fecal contamination of drinking water within peri-urban households, Lima, Peru. Am J Trop Med Hyg (2007) 1.72
Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70
High prevalence of HIV and syphilis in a remote native community of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.70
Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis (2008) 1.70
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses (2006) 1.67
Patterns and causes of species richness: a general simulation model for macroecology. Ecol Lett (2009) 1.67
Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol (2004) 1.66
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev (2016) 1.66
Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65
Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64
Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg (2008) 1.62
Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One (2008) 1.61
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med (2002) 1.61
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis (2004) 1.60
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart (2011) 1.60
Educational programs to enhance medical expertise in tropical diseases: the Gorgas Course experience 1996-2001. Am J Trop Med Hyg (2002) 1.60
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis (2010) 1.60
Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep (2011) 1.59
Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. Lancet (2005) 1.57